Demo data. These are fictitious sample companies used to preview GroWiser. The figures are not real and are not investment information.
Himgiri Pharma Ltd
NSE: HIMGIRIPHBSE: 514760Pharma Formulations
₹2,019.55
▲ 30.30 (+1.52%)
Quarterly Results
- Jun '25: 1,133
- Sep '25: 1,158
- Dec '25: 1,327
- Mar '26: 1,273
- Jun '26: 1,448
- Jun '25: 172
- Sep '25: 175
- Dec '25: 201
- Mar '26: 193
- Jun '26: 207
- Jun '25: ₹15.74
- Sep '25: ₹16.09
- Dec '25: ₹18.44
- Mar '26: ₹17.69
- Jun '26: ₹19.00
| ₹ Cr | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|
| Revenue from operations | 1,133 | 1,158 | 1,327 | 1,273 | 1,448 |
| Operating expenses | 856 | 875 | 1,003 | 962 | 1,089 |
| Operating profit (EBITDA) | 277 | 283 | 324 | 311 | 358 |
| Other income | 22 | 22 | 26 | 25 | 7 |
| Depreciation | 53 | 54 | 62 | 60 | 68 |
| Interest | 17 | 17 | 20 | 19 | 21 |
| Profit before tax | 229 | 234 | 268 | 257 | 276 |
| Tax | 57 | 58 | 67 | 64 | 69 |
| Net profit | 172 | 175 | 201 | 193 | 207 |
| EPS (₹) | 15.74 | 16.09 | 18.44 | 17.69 | 19.00 |
Figures in ₹ Cr unless marked per share (₹). Consolidated.
Showing 5 of 12 periods. Premium unlocks the full 10-year history. See Premium